Autoimmune progesterone dermatitis

Authors

  • Felicitas Peirano Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina
  • Jesica Radonich Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina
  • Alejandro Sanz Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina
  • Miguel Ángel Mazzini Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina
  • Florencia Galván Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v26i4.2157

Keywords:

autoimmune progesterone dermatitis, desensitization treatment with autologous progesterone

Abstract

Autoimmune progesterone dermatitis is described as an hypersensitivity reaction to endogenous and/or exogenous progesterone. It affects women of childbearing age, decreasing its frequency during pregnancy. The clinical presentation is heterogeneous and skin lesions develop cyclically, in direct relation with the menstrual cycle. Among described treatments are the inhibition of the ovulation, desensitizing treatment and in refractory cases bilateral oophorectomy with hysterectomy can even be considered.

We present a case of autoimmune dermatitis caused by progesterone that was treated with desensitization with autologous progesterone with a good response.

Author Biographies

Felicitas Peirano, Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

Resident Medical Doctor. Dermatology Service, Churruca-Visca Hospital.

Jesica Radonich, Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

Head of Residents. Dermatology Service, Churruca-Visca Hospital.

Alejandro Sanz, Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

Medical Doctor. Dermatology Service, Churruca-Visca Hospital.

Miguel Ángel Mazzini, Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

Head of the Dermatology Service, Churruca-Visca Hospital

Florencia Galván, Churruca-Visca Hospital, Autonomous City of Buenos Aires, Argentina

Dermatology Specialist. Dermatology Service, Hospital Churruca-Visca.

References

I. Foer D, Buchheit KM. Presentation and natural history of progestegen hypersensitivity. Ann Allergy Asthma Immunol 2019;122:156-159.

II. Orta DS, Abizuri Prado MF, Lecumberri Santamaría B, Merino MB, et ál. Dermatitis autoinmune por progesterona o hipersensibilidad a la progesterona. Un nuevo caso con respuesta clínica a sulfona y revisión de la literatura. Med Cutan Iber Lat Am 2018;46:137-141.

III. Herzberg AJ, Strohmeyer CR, Cirillo-Hyland VA. Autoimmune progesterone dermatitis. J Am Acad Dermatol 1995;32:333-338.

IV. Hill JL, Carr TF. Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol. J Allergy Clin Immunol Pract 2013;1:537-538.

V. Camões S, Sampaio J, Rocha J, Tiago P, et ál. Autoimmune progesterone dermatitis: case report of an unexpected treatment reaction. Australas J Dermatol 2017;58:e132-134.

VI. Lee MK, Lee WY, Yong SJ, Shin KCH, et ál. A case of auto-inmmune progesterone dermatitis misdiagnosed as allergic contact dermatitis. Allergy Asthma Immunol Res 2011;3:141-144.

VII. Nguyen T, Razzaque Ahmed A. Autoimmune progesterone dermatitis: update and insights. Autoimmun Rev 2016;15:191-197.

VIII. Solomon M, Itsekson AM, Lev-Sagie A. Autoimmune progesterone dermatitis. Curr Derm Rep 2013;2:258-263.

IX. Baptist AP, Baldwin JL. Autoimmune progesterona dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy 2004;2:10.

X. Snyder JL, Krishnaswamy G. Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol 2003;90:469-477.

XI. Foer D, Buchheit KM, Gargiulo AR, Lynch DM, et ál. Progestogen hypersensitivity in 24 cases: diagnosis, management, and proposed renaming and classification. J Allergy Clin Immunol Pract 2016;4:723-729.

XII. Frieder J, Younus M. Autoimmune progesterone dermatitis with delayed intradermal skin reaction: a case report. Ann Allergy Asthma Immunol 2016;117:438-439.

Published

2020-12-20